Last reviewed · How we verify
MMT 98 Study For Metastatic Disease Rhabdomyosarcoma And Other Malignant Soft Tissue Sarcoma Of Childhood
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating children with metastatic rhabdomyosarcoma or other malignant mesenchymal tumors.
Details
| Lead sponsor | Societe Internationale d'Oncologie Pediatrique |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Start date | 1998-11 |
| Completion | 2010-03 |
Conditions
- Ovarian Cancer
- Sarcoma
- Small Intestine Cancer
Interventions
- dactinomycin
- filgrastim
- carboplatin
- cyclophosphamide
- doxorubicin hydrochloride
- epirubicin hydrochloride
- etoposide
- ifosfamide
- vincristine sulfate
- peripheral blood stem cell transplantation
Countries
France, Ireland, United Kingdom